“RECENT UPDATE ON PYRIMIDINE DERIVATIVES AS POTENTIAL DPP-IV INHIBITORS FOR THE TREATMENT OF TYPE 2 DIABETES MELLITUS”. Journal of Pharmaceutical Negative Results, Dec. 2022, pp. 5734-43, https://www.pnrjournal.com/index.php/home/article/view/5581.